Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Bio-Techne history
Bio-Techne company history timeline
Since 1976, R&D Systems has been making hematology controls, which are used to verify the accuracy of blood analysis instruments.
David Mundschenk founded Research and Diagnostics Systems in Minneapolis in 1976.
R&D Systems' first product, a Platelet-Rich-Plasma control, was introduced in 1977.
In 1981 R&D Systems became only the second manufacturer in the world to introduce a Whole Blood Control with Platelets.
In 1983, however, a misstep by the company founder plunged the company back into an unfavorable situation.
1985: The shell company TECHNE buys R&D Systems.
Revenues for 1991 were $22.3 million, and net income reached $1.96 million, a 17 percent increase over the previous year.
The company bought British Biotechnology Products (BBP) Limited in 1993 for $2.3 million.
1993: TECHNE buys a British biotechnology company, founds a European division.
1995: TECHNE establishes a sales subsidiary in Germany.
In 1997 TECHNE carried out a restructuring of its European operations.
Net income for 1998 reached $15.2 million on sales of $67.3 million, compared to net income of $6.7 million on sales of $47.7 million three years earlier.
Corporate Report said he ran the company with a "miser's touch" in a 1999 article in which Oland was profiled as one of the top underpaid CEOs in Minnesota.
Net income was up 60 percent in 2000 to $26.6 million on revenues of $103.8 million.
In 2005, R&D Systems acquired Fortron Bioscience, Inc., a developer and manufacturer of monoclonal and polyclonal antibodies, antigens, and other biological reagents.
Fortron was merged into R&D Systems Biotechnology Division in July 2007.
In 2007, R&D Systems established its wholly owned subsidiary in the People’s Republic of China, opening its warehouse and distribution center later that year in Shanghai.
Rate how well Bio-Techne lives up to its initial vision.
Bio-Techne jobs
Do you work at Bio-Techne?
Does Bio-Techne communicate its history to new hires?
Bio-Techne competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| CooperVision | 1958 | $1.1B | 25 | 8 |
| Steris | 1985 | $5.1B | 12,000 | 595 |
| Enzymedica | 1998 | $182.0M | 20 | 2 |
| Sartorius | 1870 | $90.6M | 50 | 40 |
| Invivoscribe | 1995 | $6.5M | 190 | 3 |
| Dentsply Sirona | 1877 | $4.2B | 16,000 | 109 |
| Invacare | 1885 | $741.7M | 3,400 | 2 |
| Moderna | 2010 | $3.2B | 2,500 | 83 |
| Bausch + Lomb | 1853 | $4.8B | 12,000 | 1,070 |
| Pentron | 1967 | $110.0M | 280 | - |
Bio-Techne history FAQs
Zippia gives an in-depth look into the details of Bio-Techne, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Bio-Techne. The employee data is based on information from people who have self-reported their past or current employments at Bio-Techne. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Bio-Techne. The data presented on this page does not represent the view of Bio-Techne and its employees or that of Zippia.
Bio-Techne may also be known as or be related to BIO TECHNE CORP, Bio-Techne, Bio-Techne Corp., Bio-Techne Corporation and Bio-techne.